With the capital raised to date, the company has extended its cash runway until the end of the first quarter of 2027.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INTS:
- Intensity Therapeutics Enters Securities Purchase Agreement
- Intensity Therapeutics prices 5M shares at 80c in registered direct offering
- Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
- Why Is Intensity Therapeutics Stock (INTS) Up 195% Today?
- Intensity Therapeutics’ INT230-6 antitumor effect featured in published study
